title: Should we add screening for and treating left ventricular hypertrophy to the management of all patients needing secondary prevention of cardiovascular disease?
authors.affiliation: Department of Clinical Pharmacology and Therapeutics, Ninewells Hospital, Dundee, UK. a.d.struthers@dundee.ac.uk
authors.forename: A D
authors.initials: AD
authors.lastname: Struthers
authors.forename: J
authors.initials: J
authors.lastname: Davies
mesh_terms: D001794:Blood Pressure / Q000502:physiology; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis* / Q000628:therapy; D008403:Mass Screening / Q000379:methods; D012307:Risk Factors